Nuzenio

Firstword Pharma Former

Firstword Pharma Former entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Replimune wins on third try as FDA clears Tudriqev for melanoma - FirstWord PHARMAFirstWord PHARMA · Fri, 07 Aug 2026 00:57:10 GMT Braveheart's shares soar after raising $384M in its debut - FirstWord PHARMAFirstWord PHARMA · Thu, 06 Aug 2026 20:57:08 GMT Friday Five – The short-lived story of BristolZeneca...and more from a busy week in biopharma - FirstWord PHARMAFirstWord PHARMA · Thu, 06 Aug 2026 14:56:57 GMT CDC gets permanent chief after almost year-long leadership vacuum - FirstWord PHARMAFirstWord PHARMA · Thu, 06 Aug 2026 01:26:57 GMT Roche-backed Mironid gets $46M boost to put rare kidney disease drug on path to clinic - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 08:06:57 GMT Amgen remains bullish on Repatha, axes obesity asset in 2Q report - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 01:51:57 GMT AstraZeneca, BMS reportedly in $400B merger talks - FirstWord PHARMAFirstWord PHARMA · Mon, 03 Aug 2026 04:16:55 GMT Spotlight On: Novo Nordisk's not-so-near miss at ex-obesity success - FirstWord PHARMAFirstWord PHARMA · Mon, 03 Aug 2026 02:56:54 GMT

Timeline

Fri, 07 Aug 2026 00:57:10 GMTReplimune wins on third try as FDA clears Tudriqev for melanoma - FirstWord PHARMA

Thu, 06 Aug 2026 20:57:08 GMTBraveheart's shares soar after raising $384M in its debut - FirstWord PHARMA

Thu, 06 Aug 2026 14:56:57 GMTFriday Five – The short-lived story of BristolZeneca...and more from a busy week in biopharma - FirstWord PHARMA

Thu, 06 Aug 2026 01:26:57 GMTCDC gets permanent chief after almost year-long leadership vacuum - FirstWord PHARMA

Wed, 05 Aug 2026 08:06:57 GMTRoche-backed Mironid gets $46M boost to put rare kidney disease drug on path to clinic - FirstWord PHARMA

Wed, 05 Aug 2026 01:51:57 GMTAmgen remains bullish on Repatha, axes obesity asset in 2Q report - FirstWord PHARMA

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

FirstWord PHARMA FirstWord8 live mentions PHARMA8 live mentions FDA2 live mentions Tudriqev2 live mentions BristolZeneca2 live mentions Mironid2 live mentions Repatha2 live mentions BMS2 live mentions Novo Nordisk2 live mentions Replimune1 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Firstword Pharma Former.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.